Dominik Mertz, University of Ottawa

Research

Antimicrobial Resistance Biomarker C.Difficile Infection Chimeric Antigen Receptor T-Cell Therapy Feasibility Hematopoietic Stem Cell Transplantation Microbiome Pilot

Latest papers

Trends in health care–associated infections in acute care hospitals in Canada: an analysis of repeated point-prevalence surveys
CANADIAN MEDICAL ASSOCIATION JOURNAL · 2019
The evolving epidemiology of Clostridium difficile infection in Canadian hospitals during a postepidemic period (2009–2015)
CANADIAN MEDICAL ASSOCIATION JOURNAL · 2018

All 2 publications

Latest funding

Oral Vancomycin for the Prevention of C. difficile Infection in High-Risk HCT and CAR-T Patients (VAPOR-HCT): A Pilot Randomized Placebo-Controlled Trial
CIHR · 2025 · Principal investigator
$100,000

All 1 grants and awards

2 publications.

01

Trends in health care–associated infections in acute care hospitals in Canada: an analysis of repeated point-prevalence surveys

Mitchell R, Taylor G, Rudnick W, Alexandre S, Bush K, Forrester L, Frenette C, Granfield B, Gravel-Tropper D, Happe J

CANADIAN MEDICAL ASSOCIATION JOURNAL201961 citations

DOI: 10.1503/cmaj.190361

02

The evolving epidemiology of Clostridium difficile infection in Canadian hospitals during a postepidemic period (2009–2015)

Katz KC, Golding GR, Choi KB, Pelude L, Amaratunga KR, Taljaard M, Alexandre S, Collet JC, Davis I, Du T

CANADIAN MEDICAL ASSOCIATION JOURNAL201863 citations

DOI: 10.1503/cmaj.180013

Oral Vancomycin for the Prevention of C. difficile Infection in High-Risk HCT and CAR-T Patients (VAPOR-HCT): A Pilot Randomized Placebo-Controlled Trial

Principal investigatorCIHR2025Project Grant - Priority Announcement - Cancer Survivorship

Principal investigators: MacFadden, Derek R; Atkins, Harold L; Buchan, Catharine A; Cheng, Matthew P; Climans, Troy; Coburn, Bryan A; Daneman, Nick; Gauthier, Karine; Hay, Annette; Kabbani, Dima; Kekre, Natasha; Kennah, Michael; McIntyre, Lauralyn A; Mertz, Dominik; Monteith, Bethany E; Mortimer, Leanne M; Purssell, Andrew; Taljaard, Monica; Tsang, Corey

Keywords: Antimicrobial Resistance; Biomarker; C.Difficile Infection; Chimeric Antigen Receptor T-Cell Therapy; Feasibility; Hematopoietic Stem Cell Transplantation; Microbiome; Pilot; Prophylaxis; Randomized Trial

$100,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Frequent collaborators

Medicine
Infectious Diseases
Department of Laboratory Medicine and Pathobiology
Human Nutrition
Nephrology
School of Epidemiology and Public Health
Pediatrics
Other

1 shared papers, latest 2019

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2025

Subject: Prospective PhD student: Antimicrobial Resistance Dear Professor Mertz, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Trends in health care–associated infections in acute care hospitals in Canada: an analysis of repeated point-prevalence surveys" (2019), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Oral Vancomycin for the Prevention of C. difficile Infection in High-Risk HCT and CAR-T Patients (VAPOR-HCT): A Pilot Randomized Placebo-Controlled Trial" (2025), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]